Oak Longevity vs Hers: Compounded vs FDA-Approved Options
Oak Longevity vs Hers is a direct comparison of price, medication type, care model, membership requirements, and shipping or coaching. Early verdict: Oak Longevity is positioned for cost-conscious patients seeking low-priced compounded GLP-1s with no membership, while Hers focuses on FDA-approved Wegovy plus a personalized care team and ongoing dose check-ins.
See Oak Longevity pricing and options
Key differences at a glance: Oak Longevity vs Hers
This comparison highlights five supported differences: starting price and pricing model, medication type and regulatory status, membership and billing, care and clinical review process, and included services like shipping and coaching.
| Criteria | Oak Longevity | Hers |
|---|---|---|
| Starting price | Semaglutide from $133/mo; tirzepatide from $199/mo | Wegovy pill from $149/mo; injectable from $199/mo |
| Medication type | Compounded semaglutide and tirzepatide | FDA-approved Wegovy and other brand-name GLP-1s, not compounded |
| Membership or subscription | No subscriptions or membership fees; billed monthly on a non-recurring basis | Active Hers Weight Loss Membership required; membership fee billed separately |
| Care model and review | Asynchronous clinical review, no video call required; board-certified physicians review cases | Personalized care team with ongoing dose check-ins and doctor-trusted GLP-1s |
| Included services | Free health coaching and free shipping with tracking | Name brand medication, personalized care team; shipping and availability vary |
| Regulatory note | Compounded medications are not FDA-approved finished products | Offers FDA-approved options such as Wegovy |
Pricing and billing: who pays less up front
Oak Longevity advertises semaglutide from $133/month and tirzepatide from $199/month with one flat price covering all dosages and no subscription. Hers lists brand-name Wegovy pill from $149/month and injectable options from $199/month but requires an active membership; a membership fee is billed separately and medication is not available without it. If your main objective is lowest advertised monthly medication price without recurring membership fees, Oak Longevity is presented as the lower-cost option.
Medication type and regulatory status
Oak Longevity offers compounded semaglutide and tirzepatide. The source specifies that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers offers FDA-approved Wegovy and other brand-name GLP-1s, not compounded products. That distinction is central: Oak emphasizes lower-priced compounded options, while Hers emphasizes FDA-approved brand-name medications.
Membership, renewals, and cancellation differences
Oak states billing is monthly on a non-recurring basis with no subscription, and three-month prescriptions are billed upfront. Oak also notes no refunds are available after physician approval and once medication has shipped. Hers requires an active Hers Weight Loss Membership for medication access; membership and medication are billed separately. The Hers source warns medication is not available without an active membership and membership auto-renews at the stated rates.
View Hers membership and pricing
Care model and included services
Oak offers free health coaching included with every plan, free shipping with tracking, and an asynchronous clinician review process so no video call is required. Oak also notes board-certified physicians in your state review every case. Hers highlights a personalized care team with ongoing dose check-ins and promotes doctor-trusted, FDA-approved options. Choose based on whether you prefer included coaching and asynchronous review or ongoing team-based dose management with an active membership.
Safety, eligibility, and important limits
Both sources include regulatory notes. Oak explicitly states compounded medications are not FDA-approved finished products and treatment is available only when a licensed clinician determines it is medically appropriate. Oak also notes patients with BMI below 20 do not qualify for GLP-1 treatment and not for patients under 18, pregnant, or nursing. Hers notes Wegovy and Zepbound are FDA-approved for weight loss and that Ozempic and Mounjaro are FDA-approved for type 2 diabetes and may be prescribed off-label. Hers also states treatments are available only when a licensed clinician determines they are medically appropriate and that not all 50 states may be covered.
Conclusion: Oak Longevity vs Hers
Oak Longevity vs Hers comes down to priorities. Oak Longevity is presented for cost-conscious patients seeking compounded semaglutide or tirzepatide at lower advertised prices with no subscription and included coaching and shipping. Hers is presented for patients who prioritize FDA-approved brand-name Wegovy and an ongoing personalized care team but must accept a membership requirement and separate membership fee. Oak Longevity vs Hers: choose based on whether price and no-membership matter more, or whether brand-name FDA approval and dose check-ins matter more.
Choose Oak Longevity if you want lower starting prices, one flat price for all dosages, no subscription or membership, free health coaching, and free shipping with an asynchronous clinical review.
Choose Hers if you want FDA-approved Wegovy or other brand-name GLP-1s and a personalized care team with ongoing dose check-ins and accept the requirement of an active membership.